Akèy › Kansè Metastatik › Vermont › Burlington
Etid klinik pou Kansè Metastatik nan Burlington, VT
4 etid pou Kansè Metastatik ap chèche patisipan nan sit nan ak bò kote Burlington (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Ap rekriteFaz 3
- The University of Vermont Medical Center Inc., Burlington
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Ap rekriteFaz 3
- The University of Vermont Medical Center Inc., Burlington
FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
Ap rekriteFaz 1
- University of Vermont Medical Center, Burlington
Hybrid Arc Palliative Radiation Therapy (HART): A Single Arm Phase II Trial
Ap rekriteFaz 2
- University of Vermont Medical Center, Burlington
Etid Kansè Metastatik nan lòt vil
- Houston, TX104 etid
- New York City, NY93 etid
- Nashville, TN70 etid
- Boston, MA63 etid
- Los Angeles, CA57 etid
- St. Louis, MO54 etid
- Arlington, VA53 etid
- Philadelphia, PA46 etid
- Chicago, IL45 etid
- San Antonio, TX44 etid
- Washington, DC43 etid
- Dallas, TX42 etid
Lòt etid nan Burlington
- Ensifizyans kadyak8 etid
- Leksemi mieloïd egi7 etid
- Kansè (tout kalite)6 etid
- BPCO5 etid
- Kansè nan tete5 etid
- Leukemi4 etid
- Maladi Parkinson4 etid
- Kansè poumon4 etid
- Maladi kadyovaskilè4 etid
- Fibroz sistik4 etid
- Kansè Poumon ki pa ti selil4 etid
- Kansè pwostat4 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.